Clinical Trial Update: Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating combination chemotherapy for relapsed or refractory acute lymphoblastic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Snippet

Sponsor: Hannover Medical School | Conditions: Leukemia | Phase 2 | Status: UNKNOWN